Reynolds Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$584K Hold
4,200
1.01% 21
2015
Q4
$586K Hold
4,200
0.64% 40
2015
Q3
$588K Sell
4,200
-1,400
-25% -$210K 0.74% 39
2015
Q2
$919K Sell
5,600
-700
-11% -$112K 0.9% 19
2015
Q1
$973K Buy
6,300
+2,100
+50% +$299K 0.85% 20
2014
Q4
$528K Sell
4,200
-400
-9% -$49.4K 0.44% 67
2014
Q3
$550K Buy
4,600
+1,300
+39% +$149K 0.53% 51
2014
Q2
$355K Buy
3,300
+800
+32% +$82.4K 0.24% 161
2014
Q1
$249K Sell
2,500
-800
-24% -$72.4K 0.16% 285
2013
Q4
$305K Buy
3,300
+500
+18% +$44.4K 0.17% 240
2013
Q3
$234K Sell
2,800
-900
-24% -$77.1K 0.15% 294
2013
Q2
$303K Buy
+3,700
New +$277K 0.22% 184

Other funds holding ELV

Reynolds Capital Management's ELV Position: Q1 2016 in Review

Reynolds Capital Management held its Elevance Health (ELV) position steady in Q1 2016 at 4,200 shares worth $584K. The position accounts for 1.01% of the portfolio, ranked #21.

Reynolds Capital Management first reported a position in ELV in Q2 2013 and has held it in 12 quarters since. The position peaked at $973K in Q1 2015. 771 funds tracked by Wall St. Rank hold ELV as of Q1 2016.

  • Reynolds Capital Management held 4,200 shares of Elevance Health worth $584K as of Q1 2016.
  • Reynolds Capital Management left its Elevance Health share count unchanged in Q1 2016.
  • Elevance Health made up 1.01% of Reynolds Capital Management's portfolio in Q1 2016, its #21 holding.
  • Reynolds Capital Management first reported a position in Elevance Health in Q2 2013 and has held it in 12 quarters since.
  • Reynolds Capital Management's Elevance Health position peaked at $973K in Q1 2015.
  • 771 funds tracked by Wall St. Rank held Elevance Health as of Q1 2016.

Based on Reynolds Capital Management's 13F filing for Q1 2016, filed 13 May 2016.